Insights

Artificial Intelligence (AI) is bringing about a paradigm shift in healthcare, powered by the increasing availability of medical data and the rapid progress of analytical techniques. From catalyzing drug discovery to using data-driv...

The global biosimilar market is expected to reach USD 36 billion by 2022. However, only some countries are favorable for biosimilars due to reasons ranging from poor accessibility to unconducive regulatory environments. This infogra...